BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Lipopolysaccharide, rs6983267, VEGFA, glucose metabolic process, Arthritis, Breast)
Bookmark Forward

QuickView for arecoline (compound)


Genetic Markers

Most Correlated Genes

  1. SDHC
  2. TFCP2
  3. APP
  4. KPNB1
  5. PRRC2A
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN
  2. AACTGAC_MIR223
  3. SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY
  4. JOHNSTONE_PARVB_TARGETS_1_DN
  5. GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Broad Connectivity Map (CMAP 2.0) compound database
  2. Acute monocytic leukemia THP1 cells treated with 3-methylnitrosaminopropionaldehyde or arecoline
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Determination of arecoline in areca nut based on field amplification in capillary electrophoresis co…
  2. Assessment of the mutagenic potential of arecoline in gpt delta transgenic mice.
  3. Frequency- and state-dependent blockade of human ether-a-go-go-related gene K+ channel by arecoline …
  4. Arecoline inhibits myogenic differentiation of C2C12 myoblasts by reducing STAT3 phosphorylation.
  5. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathog…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. The Relation of Microtubule-Associated Protein 2 and Cell Migration
  2. Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Or…
  3. The Occurrence of Periopathogens in Betel-Nut Chewers and the Effects of Areca-Nut on Periopathogens
  4. Testing the Effectiveness of a Betel Nut Cessation Program
  5. Adapting a Betel Quid Cessation Program for a High-risk Community in Malaysia and Evaluating Its Eff…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.